MRI features of demyelinating disease associated with anti-MOG antibodies in adults.


Journal

Journal of neuroradiology = Journal de neuroradiologie
ISSN: 0150-9861
Titre abrégé: J Neuroradiol
Pays: France
ID NLM: 7705086

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 24 05 2019
revised: 30 05 2019
accepted: 03 06 2019
pubmed: 23 6 2019
medline: 24 4 2020
entrez: 23 6 2019
Statut: ppublish

Résumé

The spectrum of Myelin Oligodendrocytes Glycoprotein (MOG) antibody disease constitutes a recently described challenging entity, referring to a relatively new spectrum of autoimmune disorders with antibodies against MOG predominantly involving the optic nerve and spinal cord. The purpose of this article is to describe MRI features of MOG-AD involvement in the optic nerves, spinal cord and the brain of adults.

Identifiants

pubmed: 31228536
pii: S0150-9861(19)30304-9
doi: 10.1016/j.neurad.2019.06.001
pii:
doi:

Substances chimiques

Autoantibodies 0
MOG protein, human 0
Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

312-318

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Marc Denève (M)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France. Electronic address: denevemarc@free.fr.

Damien Biotti (D)

Neurology department, Pierre-Paul Riquet/Purpan university hospital, 31300 Toulouse, France.

Sofia Patsoura (S)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.

Marine Ferrier (M)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.

Zuzana Meluchova (Z)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.

Laurence Mahieu (L)

Ophthalmology department, Pierre-Paul Riquet/Purpan university hospital, 31300 Toulouse, France.

Françoise Heran (F)

Radiology department, fondation A.-De Rothschild, 75019 Paris, France.

Catherine Vignal (C)

Ophthalmology department, fondation A.-De Rothschild, 75019 Paris, France.

Romain Deschamps (R)

Neurology department, fondation A.-De Rothschild, 75019 Paris, France.

Olivier Gout (O)

Neurology department, fondation A.-De Rothschild, 75019 Paris, France.

Nicolas Menjot de Champfleur (NM)

Neuroradiology department, CHU de Montpellier, 34295 Montpellier, France.

Xavier Ayrignac (X)

Neurology department, CHU de Montpellier, 34295 Montpellier, France.

Clarisse Carra Dallière (CC)

Neurology department, CHU de Montpellier, 34295 Montpellier, France.

Pierre Labauge (P)

Neurology department, CHU de Montpellier, 34295 Montpellier, France.

Cécile Dulau (C)

Neurology department, CHU de Bordeaux, 33000 Bordeaux, France.

Thomas Tourdias (T)

Neuroradiology department, CHU de Bordeaux, 33000 Bordeaux, France.

Hervé Dumas (H)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.

Christophe Cognard (C)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France.

David Brassat (D)

Neurology department, Pierre-Paul Riquet/Purpan university hospital, 31300 Toulouse, France.

Fabrice Bonneville (F)

Neuroradiology department, Pierre-Paul-Riquet/Purpan university hospital, 31300 Toulouse, France. Electronic address: bonneville.f@chu-toulouse.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH